Annual CFO
$13.86 B
+$794.00 M+6.08%
31 December 2023
Summary:
Bristol-Myers Squibb annual cash flow from operations is currently $13.86 billion, with the most recent change of +$794.00 million (+6.08%) on 31 December 2023. During the last 3 years, it has fallen by -$192.00 million (-1.37%). BMY annual CFO is now -14.48% below its all-time high of $16.21 billion, reached on 31 December 2021.BMY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$5.59 B
+$3.27 B+140.37%
30 September 2024
Summary:
Bristol-Myers Squibb quarterly cash flow from operations is currently $5.59 billion, with the most recent change of +$3.27 billion (+140.37%) on 30 September 2024. Over the past year, it has increased by +$840.00 million (+17.68%). BMY quarterly CFO is now at all-time high.BMY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$15.00 B
+$840.00 M+5.93%
30 September 2024
Summary:
Bristol-Myers Squibb TTM cash flow from operations is currently $15.00 billion, with the most recent change of +$840.00 million (+5.93%) on 30 September 2024. Over the past year, it has increased by +$2.09 billion (+16.18%). BMY TTM CFO is now -7.43% below its all-time high of $16.21 billion, reached on 31 December 2021.BMY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +6.1% | +17.7% | +16.2% |
3 y3 years | -1.4% | +6.2% | -3.2% |
5 y5 years | +96.2% | +118.7% | +56.5% |
BMY Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -14.5% | +6.1% | at high | +196.3% | -7.4% | +26.6% |
5 y | 5 years | -14.5% | +96.2% | at high | +196.3% | -7.4% | +82.7% |
alltime | all time | -14.5% | +1366.7% | at high | +614.8% | -7.4% | +3817.2% |
Bristol-Myers Squibb Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $5.59 B(+140.4%) | $15.00 B(+5.9%) |
June 2024 | - | $2.33 B(-17.9%) | $14.16 B(+3.2%) |
Mar 2024 | - | $2.83 B(-33.3%) | $13.72 B(-1.0%) |
Dec 2023 | $13.86 B(+6.1%) | $4.25 B(-10.5%) | $13.86 B(+7.3%) |
Sept 2023 | - | $4.75 B(+151.8%) | $12.91 B(+9.0%) |
June 2023 | - | $1.89 B(-36.5%) | $11.85 B(-3.1%) |
Mar 2023 | - | $2.97 B(-10.2%) | $12.22 B(-6.4%) |
Dec 2022 | $13.07 B(-19.4%) | $3.31 B(-10.3%) | $13.07 B(-5.4%) |
Sept 2022 | - | $3.69 B(+63.1%) | $13.82 B(-10.3%) |
June 2022 | - | $2.26 B(-40.7%) | $15.40 B(-4.9%) |
Mar 2022 | - | $3.81 B(-6.0%) | $16.20 B(-0.1%) |
Dec 2021 | $16.21 B(+15.3%) | $4.06 B(-23.0%) | $16.21 B(+4.5%) |
Sept 2021 | - | $5.27 B(+72.1%) | $15.51 B(+24.0%) |
June 2021 | - | $3.06 B(-20.0%) | $12.51 B(-10.3%) |
Mar 2021 | - | $3.82 B(+14.0%) | $13.94 B(-0.8%) |
Dec 2020 | $14.05 B(+71.2%) | $3.35 B(+48.0%) | $14.05 B(+9.1%) |
Sept 2020 | - | $2.27 B(-49.5%) | $12.88 B(-2.2%) |
June 2020 | - | $4.49 B(+14.1%) | $13.17 B(+22.4%) |
Mar 2020 | - | $3.94 B(+80.5%) | $10.76 B(+31.0%) |
Dec 2019 | $8.21 B(+16.2%) | $2.18 B(-14.7%) | $8.21 B(-14.3%) |
Sept 2019 | - | $2.56 B(+22.7%) | $9.58 B(+15.4%) |
June 2019 | - | $2.08 B(+49.9%) | $8.31 B(+14.1%) |
Mar 2019 | - | $1.39 B(-60.9%) | $7.28 B(+3.0%) |
Dec 2018 | $7.07 B(+34.0%) | $3.56 B(+178.0%) | $7.07 B(+52.7%) |
Sept 2018 | - | $1.28 B(+21.0%) | $4.63 B(-8.6%) |
June 2018 | - | $1.06 B(-10.0%) | $5.06 B(-9.4%) |
Mar 2018 | - | $1.18 B(+5.2%) | $5.59 B(+6.0%) |
Dec 2017 | $5.28 B(+72.5%) | $1.12 B(-34.8%) | $5.28 B(-5.8%) |
Sept 2017 | - | $1.71 B(+8.1%) | $5.60 B(+5.8%) |
June 2017 | - | $1.58 B(+84.0%) | $5.29 B(+27.6%) |
Mar 2017 | - | $861.00 M(-40.3%) | $4.15 B(+35.6%) |
Dec 2016 | $3.06 B(+45.3%) | $1.44 B(+2.8%) | $3.06 B(+22.4%) |
Sept 2016 | - | $1.40 B(+219.8%) | $2.50 B(+54.4%) |
June 2016 | - | $439.00 M(-292.5%) | $1.62 B(+29.4%) |
Mar 2016 | - | -$228.00 M(-125.8%) | $1.25 B(-40.6%) |
Dec 2015 | $2.10 B(-33.1%) | $884.00 M(+68.7%) | $2.10 B(+17.4%) |
Sept 2015 | - | $524.00 M(+638.0%) | $1.79 B(-17.4%) |
June 2015 | - | $71.00 M(-88.7%) | $2.17 B(-31.2%) |
Mar 2015 | - | $626.00 M(+9.4%) | $3.16 B(+0.3%) |
Dec 2014 | $3.15 B(-11.2%) | $572.00 M(-36.7%) | $3.15 B(-21.0%) |
Sept 2014 | - | $903.00 M(-14.5%) | $3.99 B(-3.6%) |
June 2014 | - | $1.06 B(+71.2%) | $4.14 B(-9.9%) |
Mar 2014 | - | $617.00 M(-56.2%) | $4.59 B(+29.5%) |
Dec 2013 | $3.54 B(-48.9%) | $1.41 B(+33.9%) | $3.54 B(+19.3%) |
Sept 2013 | - | $1.05 B(-30.3%) | $2.97 B(-54.3%) |
June 2013 | - | $1.51 B(-452.8%) | $6.50 B(+6.1%) |
Mar 2013 | - | -$428.00 M(-151.2%) | $6.13 B(-11.7%) |
Dec 2012 | $6.94 B(+43.4%) | $836.00 M(-81.8%) | $6.94 B(-9.5%) |
Sept 2012 | - | $4.58 B(+304.2%) | $7.67 B(+60.3%) |
June 2012 | - | $1.13 B(+193.0%) | $4.79 B(+0.9%) |
Mar 2012 | - | $387.00 M(-75.3%) | $4.75 B(-1.9%) |
Dec 2011 | $4.84 B(+7.8%) | $1.57 B(-7.7%) | $4.84 B(-0.6%) |
Sept 2011 | - | $1.70 B(+55.4%) | $4.87 B(+6.9%) |
June 2011 | - | $1.09 B(+127.2%) | $4.55 B(+1.0%) |
Mar 2011 | - | $481.00 M(-69.8%) | $4.51 B(+0.4%) |
Dec 2010 | $4.49 B(+10.5%) | $1.59 B(+15.3%) | $4.49 B(+5.9%) |
Sept 2010 | - | $1.38 B(+31.8%) | $4.24 B(-2.1%) |
June 2010 | - | $1.05 B(+126.1%) | $4.33 B(+6.2%) |
Mar 2010 | - | $464.00 M(-65.5%) | $4.08 B(+0.3%) |
Dec 2009 | $4.07 B(+9.7%) | $1.34 B(-8.8%) | $4.07 B(+31.7%) |
Sept 2009 | - | $1.47 B(+85.1%) | $3.09 B(+0.7%) |
June 2009 | - | $796.00 M(+76.1%) | $3.07 B(-9.4%) |
Mar 2009 | - | $452.00 M(+23.5%) | $3.38 B(-8.7%) |
Dec 2008 | $3.71 B(+17.6%) | $366.00 M(-74.8%) | $3.71 B(-6.6%) |
Sept 2008 | - | $1.45 B(+30.3%) | $3.97 B(+23.5%) |
June 2008 | - | $1.11 B(+43.7%) | $3.22 B(+1.7%) |
Mar 2008 | - | $775.00 M(+23.0%) | $3.16 B(+0.3%) |
Dec 2007 | $3.15 B | $630.00 M(-9.6%) | $3.15 B(+15.3%) |
Sept 2007 | - | $697.00 M(-34.3%) | $2.73 B(-8.3%) |
June 2007 | - | $1.06 B(+38.7%) | $2.98 B(+7.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2007 | - | $765.00 M(+262.6%) | $2.77 B(+32.7%) |
Dec 2006 | $2.08 B(+13.5%) | $211.00 M(-77.6%) | $2.08 B(-4.0%) |
Sept 2006 | - | $944.00 M(+11.7%) | $2.17 B(+9.3%) |
June 2006 | - | $845.00 M(+918.1%) | $1.99 B(+74.7%) |
Mar 2006 | - | $83.00 M(-72.1%) | $1.14 B(-38.1%) |
Dec 2005 | $1.84 B(-42.2%) | $297.00 M(-60.9%) | $1.84 B(-17.4%) |
Sept 2005 | - | $760.00 M(<-9900.0%) | $2.22 B(+8.8%) |
June 2005 | - | -$4.00 M(-100.5%) | $2.04 B(-29.0%) |
Mar 2005 | - | $783.00 M(+14.6%) | $2.88 B(-9.4%) |
Dec 2004 | $3.18 B(-9.6%) | $683.00 M(+17.6%) | $3.18 B(-15.2%) |
Sept 2004 | - | $581.00 M(-30.1%) | $3.74 B(-9.0%) |
June 2004 | - | $831.00 M(-23.1%) | $4.11 B(-7.2%) |
Mar 2004 | - | $1.08 B(-13.6%) | $4.43 B(+26.2%) |
Dec 2003 | $3.51 B(+271.6%) | $1.25 B(+31.5%) | $3.51 B(+19.1%) |
Sept 2003 | - | $951.00 M(-17.3%) | $2.95 B(+0.5%) |
June 2003 | - | $1.15 B(+618.8%) | $2.94 B(+34.0%) |
Mar 2003 | - | $160.00 M(-76.7%) | $2.19 B(+131.9%) |
Dec 2002 | $945.00 M(-82.5%) | $688.00 M(-26.6%) | $945.00 M(-57.5%) |
Sept 2002 | - | $937.00 M(+130.8%) | $2.22 B(-5.0%) |
June 2002 | - | $406.00 M(-137.4%) | $2.34 B(-32.1%) |
Mar 2002 | - | -$1.09 B(-155.2%) | $3.45 B(-36.2%) |
Dec 2001 | $5.40 B(+16.1%) | $1.97 B(+86.7%) | $5.40 B(+2.8%) |
Sept 2001 | - | $1.05 B(-30.4%) | $5.26 B(-2.5%) |
June 2001 | - | $1.51 B(+74.2%) | $5.39 B(+12.0%) |
Mar 2001 | - | $869.00 M(-52.3%) | $4.82 B(+3.5%) |
Dec 2000 | $4.65 B(+10.1%) | $1.82 B(+53.2%) | $4.65 B(+6.2%) |
Sept 2000 | - | $1.19 B(+26.7%) | $4.38 B(+2.3%) |
June 2000 | - | $938.00 M(+32.9%) | $4.28 B(+1.7%) |
Mar 2000 | - | $706.00 M(-54.5%) | $4.21 B(-0.4%) |
Dec 1999 | $4.22 B(+11.7%) | $1.55 B(+42.5%) | $4.22 B(+11.8%) |
Sept 1999 | - | $1.09 B(+25.8%) | $3.78 B(-5.8%) |
June 1999 | - | $865.00 M(+20.0%) | $4.01 B(+10.7%) |
Mar 1999 | - | $721.00 M(-34.8%) | $3.62 B(-4.2%) |
Dec 1998 | $3.78 B(+52.7%) | $1.10 B(-16.2%) | $3.78 B(+15.7%) |
Sept 1998 | - | $1.32 B(+175.9%) | $3.27 B(+17.8%) |
June 1998 | - | $478.00 M(-45.7%) | $2.78 B(+4.0%) |
Mar 1998 | - | $880.00 M(+48.4%) | $2.67 B(+7.8%) |
Dec 1997 | $2.48 B(-6.2%) | $593.00 M(-28.1%) | $2.48 B(-2.6%) |
Sept 1997 | - | $825.00 M(+122.4%) | $2.54 B(+3.4%) |
June 1997 | - | $371.00 M(-46.0%) | $2.46 B(-9.4%) |
Mar 1997 | - | $687.00 M(+4.4%) | $2.71 B(+2.7%) |
Dec 1996 | $2.64 B(+5.7%) | $658.00 M(-11.3%) | $2.64 B(+0.6%) |
Sept 1996 | - | $742.00 M(+18.5%) | $2.63 B(-0.9%) |
June 1996 | - | $626.00 M(+1.8%) | $2.65 B(+12.2%) |
Mar 1996 | - | $615.00 M(-4.2%) | $2.36 B(-5.5%) |
Dec 1995 | $2.50 B(+8.6%) | $642.00 M(-16.3%) | $2.50 B(-0.5%) |
Sept 1995 | - | $767.00 M(+127.6%) | $2.51 B(+12.7%) |
June 1995 | - | $337.00 M(-55.2%) | $2.23 B(-5.5%) |
Mar 1995 | - | $753.00 M(+15.0%) | $2.36 B(+2.5%) |
Dec 1994 | $2.30 B(-10.8%) | $655.00 M(+35.3%) | $2.30 B(-4.5%) |
Sept 1994 | - | $484.00 M(+3.9%) | $2.41 B(-11.8%) |
June 1994 | - | $466.00 M(-33.0%) | $2.73 B(-4.5%) |
Mar 1994 | - | $696.00 M(-8.9%) | $2.86 B(+11.0%) |
Dec 1993 | $2.58 B(+27.2%) | $764.00 M(-5.3%) | $2.58 B(+4.9%) |
Sept 1993 | - | $807.00 M(+35.4%) | $2.46 B(+5.1%) |
June 1993 | - | $596.00 M(+44.3%) | $2.34 B(+14.6%) |
Mar 1993 | - | $413.00 M(-35.9%) | $2.04 B(+0.7%) |
Dec 1992 | $2.03 B(+10.5%) | $644.00 M(-6.4%) | $2.03 B(-0.8%) |
Sept 1992 | - | $688.00 M(+130.9%) | $2.04 B(+10.0%) |
June 1992 | - | $298.00 M(-25.1%) | $1.86 B(-0.1%) |
Mar 1992 | - | $398.00 M(-39.7%) | $1.86 B(+1.4%) |
Dec 1991 | $1.83 B(+4.7%) | $660.00 M(+31.2%) | $1.83 B(+6.9%) |
Sept 1991 | - | $503.00 M(+67.7%) | $1.72 B(+3.7%) |
June 1991 | - | $300.00 M(-19.4%) | $1.65 B(-5.0%) |
Mar 1991 | - | $372.00 M(-31.2%) | $1.74 B(-0.6%) |
Dec 1990 | $1.75 B(+47.2%) | $541.00 M(+22.7%) | $1.75 B(+44.7%) |
Sept 1990 | - | $441.00 M(+14.0%) | $1.21 B(+57.3%) |
June 1990 | - | $387.00 M(+1.0%) | $770.00 M(+101.0%) |
Mar 1990 | - | $383.00 M | $383.00 M |
Dec 1989 | $1.19 B | - | - |
FAQ
- What is Bristol-Myers Squibb annual cash flow from operations?
- What is the all time high annual CFO for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual CFO year-on-year change?
- What is Bristol-Myers Squibb quarterly cash flow from operations?
- What is the all time high quarterly CFO for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly CFO year-on-year change?
- What is Bristol-Myers Squibb TTM cash flow from operations?
- What is the all time high TTM CFO for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM CFO year-on-year change?
What is Bristol-Myers Squibb annual cash flow from operations?
The current annual CFO of BMY is $13.86 B
What is the all time high annual CFO for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual cash flow from operations is $16.21 B
What is Bristol-Myers Squibb annual CFO year-on-year change?
Over the past year, BMY annual cash flow from operations has changed by +$794.00 M (+6.08%)
What is Bristol-Myers Squibb quarterly cash flow from operations?
The current quarterly CFO of BMY is $5.59 B
What is the all time high quarterly CFO for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly cash flow from operations is $5.59 B
What is Bristol-Myers Squibb quarterly CFO year-on-year change?
Over the past year, BMY quarterly cash flow from operations has changed by +$840.00 M (+17.68%)
What is Bristol-Myers Squibb TTM cash flow from operations?
The current TTM CFO of BMY is $15.00 B
What is the all time high TTM CFO for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM cash flow from operations is $16.21 B
What is Bristol-Myers Squibb TTM CFO year-on-year change?
Over the past year, BMY TTM cash flow from operations has changed by +$2.09 B (+16.18%)